Cargando…

Hematopoiesis of Indeterminate Potential and Atherothrombotic Risk

Hematopoiesis is the process of blood production, essential for the continued supply of immune cells and red blood cells. However, the proliferative nature of hematopoietic stem cells (HSCs) renders them susceptible to developing somatic mutations. HSCs carrying a mutation can gain a selective advan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murphy, Andrew J., Dragoljevic, Dragana, Natarajan, Pradeep, Wang, Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420552/ https://www.ncbi.nlm.nih.gov/pubmed/35445383 http://dx.doi.org/10.1055/a-1830-2147

Ejemplares similares

Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19
por: Miller, Peter G., et al.
Publicado: (2022)

Myelodysplasia Syndrome, Clonal Hematopoiesis and Cardiovascular Disease
por: Veiga, Camilla Bertuzzo, et al.
Publicado: (2021)

Clonal hematopoiesis of indeterminate potential, DNA methylation, and risk for coronary artery disease
por: Uddin, M d Mesbah, et al.
Publicado: (2022)

Birth Weight Is Associated With Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Outcomes in Adulthood
por: Schuermans, Art, et al.
Publicado: (2023)

Association of Clonal Hematopoiesis of Indeterminate Potential with Incident Heart Failure with Preserved Ejection Fraction
por: Reiner, Alex P., et al.
Publicado: (2023)

Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV
por: Bick, Alexander G., et al.
Publicado: (2022)

Patient perspectives on testing for clonal hematopoiesis of indeterminate potential
por: Sella, Tal, et al.
Publicado: (2022)

A Synopsis Clonal Hematopoiesis of Indeterminate Potential in Hematology
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Clonal hematopoiesis of indeterminate potential-related epigenetic age acceleration correlates with clonal hematopoiesis of indeterminate potential clone size in patients with high morbidity
por: Feldkamp, Jasper David, et al.
Publicado: (2022)

Healthy Lifestyle and Clonal Hematopoiesis of Indeterminate Potential: Results From the Women's Health Initiative
por: Haring, Bernhard, et al.
Publicado: (2021)

Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease
por: Huang, Yi-Chun, et al.
Publicado: (2021)

Clonal Hematopoiesis of Indeterminate Potential is Associated with Acute Kidney Injury
por: Vlasschaert, Caitlyn, et al.
Publicado: (2023)

Author Correction: Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV
por: Bick, Alexander G., et al.
Publicado: (2022)

Prevalence and significance of clonal hematopoiesis of indeterminate potential in lung transplant recipients
por: Swaminathan, Aparna C., et al.
Publicado: (2023)

Clonal Hematopoiesis of Indeterminate Potential as a Novel Risk Factor for Donor-Derived Leukemia
por: Burns, Sarah S., et al.
Publicado: (2020)

Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential in Hematology and Cardiovascular Disease
por: Hoermann, Gregor
Publicado: (2022)

Clonal Hematopoiesis of Indeterminate Potential: A Multidisciplinary Challenge in Personalized Hematology
por: Hoermann, Gregor, et al.
Publicado: (2020)

Obesity and Clonal Hematopoiesis of Indeterminate Potential: Allies in Cardiovascular Diseases and Malignancies
por: Komic, Luka, et al.
Publicado: (2023)

Association of Clonal Hematopoiesis of Indeterminate Potential with Inflammatory Gene Expression in Patients with COPD
por: Kuhnert, Stefan, et al.
Publicado: (2022)

Increased prevalence of clonal hematopoiesis of indeterminate potential in hospitalized patients with COVID-19
por: Schenz, Judith, et al.
Publicado: (2022)

Transcriptomic profiling of calcified aortic valves in clonal hematopoiesis of indeterminate potential carriers
por: Vieceli Dalla Sega, Francesco, et al.
Publicado: (2022)

Putative Mechanisms Underlying Cardiovascular Disease Associated with Clonal Hematopoiesis of Indeterminate Potential
por: Burns, Sarah S., et al.
Publicado: (2020)

Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases—an updated systematic review
por: Senguttuvan, Nagendra Boopathy, et al.
Publicado: (2021)

Clonal Hematopoiesis of Indeterminate Potential From a Heart Failure Specialist's Point of View
por: Sikking, Maurits A., et al.
Publicado: (2023)

Cholesterol Efflux Pathways Regulate Myelopoiesis: A Potential Link to Altered Macrophage Function in Atherosclerosis
por: Murphy, Andrew James, et al.
Publicado: (2014)

Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential
por: Nakao, Tetsushi, et al.
Publicado: (2022)

Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation
por: Goldman, Elisabeth A., et al.
Publicado: (2023)

EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential
por: Li, Yong, et al.
Publicado: (2022)

Leukocytes carrying Clonal Hematopoiesis of Indeterminate Potential (CHIP) Mutations invade Human Atherosclerotic Plaques
por: von Scheidt, Moritz, et al.
Publicado: (2023)

PCSK9 as an Atherothrombotic Risk Factor
por: Sotler, Tadeja, et al.
Publicado: (2023)

Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Risk in Patients with Chronic Kidney Disease without Previous Cardiac Pathology
por: Kislikova, Maria, et al.
Publicado: (2023)

Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control Study
por: Denicolò, Sara, et al.
Publicado: (2022)

Clonal hematopoiesis of indeterminate potential (CHIP): A potential contributor to atherlosclerotic cardio/cerebro-vascular diseases?
por: Li, Fei, et al.
Publicado: (2018)

Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms
por: Gagnon, Marie-France, et al.
Publicado: (2022)

Clonal hematopoiesis of indeterminate potential and its impact on patient trajectories after stem cell transplantation
por: Park, Derek S., et al.
Publicado: (2019)

P1642: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL ARE ASSOCIATED WITH INCREASED NETOSIS IN PATIENTS WITH CARDIOVASCULAR EVENTS
por: Marti, Severine, et al.
Publicado: (2023)

Response to: “Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control Study”
por: Vlasschaert, Caitlyn, et al.
Publicado: (2022)

Somatic Sequencing Identifies Trametinib-Responsive Myelodysplastic Syndrome and Finds Acquired Clonal Hematopoiesis of Indeterminate Potential
por: Vela, Cory M., et al.
Publicado: (2018)

Is the risk of cardiovascular disease altered with anti-inflammatory therapies? Insights from rheumatoid arthritis
por: Kraakman, Michael J, et al.
Publicado: (2016)

Environmental noise exposure is associated with atherothrombotic risk
por: Koczorowski, Magali, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8liiafp2s01q0htmtp1h50fprf